CML Advocates Network Newsletter: “Factors influencing adherence in CML” article now published in the Journal of Cancer Research and Clinical Oncology

 

Dear friends of the CML Advocates Network,

JOCR

 

It is a big pleasure for us to announce the publication in the Journal of Cancer Research and Clinical Oncology of our article "Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries".

 

Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries.

In  2012, the  CML  Advocates  Network decided   to   conduct   a   large, scientifically sound international study on adherence enrolling patients from 63 countries and 79 CML patient organisations based on  a  comprehensive  questionnaire  in  12  languages. 

The  aim  of  this  study  was  to  investigate motivations  and  behavioral  patterns  of  adherence  in  CML and  subsequently  support  hematologists and   patients   to   improve   adherence   and   develop   suitable   adherence   tools.   Overall   2.546 questionnaires filled in by CML patients were returned.

Our adherence research is one of the largest adherence studies made so far and very important findings on the motivations and risk factors of patients on intentional and non-intentional non-adherence, potential tools to drive adherence. We are proud of sharing with you now a great example of evidence-based patient advocacy.

paperadherence2

Now our paper has been published in the Journal of Cancer Research and Clinical Oncology

This publication has been a tough ride for us non-scientists over the past three years, given we needed support to do the data analysis and write a scientific paper. Authors were the patient advocates Jan Geissler, Giora Sharf, Mina Daban, Jan de Jong, Tony Gavin, Jana Pelouchová, Euzebiusz Jan Dziwinski, plus Dr. Verena Hoffmann who has been the scientific author, supported by Prof. Joerg Hasford!

You can access to our research on adherence on CML in our CML Education & Science website and to the complete article and pdf version HERE.

Better information on the disease, medication and management of side effects, supported by haematologists, is key to improve adherence so it would be very appreciated if you can share this key publication with the CML community.

 

Best regards,

Jan Geissler, Giora Sharf, Lidija Pecova and Celia Marín
Your CML Advocates Team

Izvor: www.cmladvocates.net

HULL Info

Hrvatska udruga leukemija i limfomi
Trg hrvatskih velikana 2/ll
10 000 Zagreb
Tel/Fax: 01 4873 561
Mob: 091 4873 561
E-mail: udruga.hull.zagreb@gmail.com
IBAN HR 36 2340 0091 1100 4711 4

Radno vrijeme:

Radno vrijeme HULL-a:
Svakim radnim danom od 09 - 16h
Predavanja i savjetovanja - drugi četvrtak u mjesecu

Sponzori

Novartis Oncology
Janssen
Roche
Genzyme
Celgene
Takeda